Details for New Drug Application (NDA): 050111
✉ Email this page to a colleague
NDA 050111 describes UNIPEN, which is a drug marketed by Wyeth Ayerst and is included in five NDAs. Additional details are available on the UNIPEN profile page.
The generic ingredient in UNIPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
The generic ingredient in UNIPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
Summary for 050111
| Tradename: | UNIPEN |
| Applicant: | Wyeth Ayerst |
| Ingredient: | nafcillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050111
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
